etomoxir has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Affleck, VS; Joshi, AR; Lin, H; Maxwell, R; Patel, S; Stoll, EA; Turnbull, DM; Wilson, I | 1 |
| Berge, K; Berge, RK; Bohov, P; Madsen, L; Tronstad, KJ | 1 |
2 other study(ies) available for etomoxir and Glioma
| Article | Year |
|---|---|
Fatty acid oxidation is required for the respiration and proliferation of malignant glioma cells.
Topics: Animals; Apoptosis; Brain Neoplasms; Cell Proliferation; Epoxy Compounds; Fatty Acids; Glioma; Glycolysis; Humans; Hypoglycemic Agents; Mice; Mice, Inbred C57BL; Neural Stem Cells; Oxidation-Reduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |
Impact of mitochondrial beta-oxidation in fatty acid-mediated inhibition of glioma cell proliferation.
Topics: Animals; Apoptosis; Carnitine; Cell Division; Epoxy Compounds; Fatty Acids; Gas Chromatography-Mass Spectrometry; Glioma; Glutathione; Humans; Mitochondria; Oxidation-Reduction; Palmitic Acid; Rats; Sphingolipids; Sulfides; Tumor Cells, Cultured | 2003 |